Global Blood-based Biomarker For Parkinson’s Disease Market Size & Outlook
Global blood-based biomarker for parkinson’s disease market, 2021-2033 (US$M)
Related Markets
Global blood-based biomarker for parkinson’s disease market highlights
- The global blood-based biomarker for parkinson’s disease market generated a revenue of USD 117.8 million in 2024 and is expected to reach USD 350.9 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 11.6% by 2033.
- In terms of segment, protein biomarkers accounted for a revenue of USD 145.5 million in 2024.
- Protein Biomarkers is the most lucrative biomarker type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
Global data book summary
| Market revenue in 2024 | USD 117.8 million |
| Market revenue in 2033 | USD 350.9 million |
| Growth rate | 11.6% (CAGR from 2025 to 2033) |
| Largest segment | Protein biomarkers |
| Fastest growing segment | Protein Biomarkers |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Protein Biomarkers |
Other key industry trends
- In terms of revenue, the North America accounted for 43.3% of the global blood-based biomarker for parkinson’s disease market in 2024.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomarker For Parkinson’s Disease Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Acobiom | View profile | 1-10 | Grabels, Languedoc-Roussillon, France, Europe | http://www.acobiom.com/en/ |
| Banyan Biomarkers | View profile | 11-50 | Alachua, Florida, United States, North America | http://banyanbio.com |
| Alseres Pharmaceuticals | View profile | 1-10 | Hopkinton, Massachusetts, United States, North America | http://www.alseres.com |
| Quanterix | View profile | 251-500 | Billerica, Massachusetts, United States, North America | http://www.quanterix.com |
| Johnson & Johnson Services, Inc. | View profile | - | - | - |
| Abbott | View profile | - | - | - |
| Rules-Based Medicine a Q Squared Solutions Company | View profile | 51-100 | Austin, Texas, United States, North America | http://rbm.q2labsolutions.com |
| DiaGenic | View profile | 11-50 | Oslo, Oslo, Norway, Europe | http://www.diagenic.com/ |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Global blood-based biomarker for parkinson’s disease market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood-based biomarker for parkinson’s disease market will help companies and investors design strategic landscapes.
Protein biomarkers was the largest segment with a revenue share of 123.51% in 2024. Horizon Databook has segmented the Global blood-based biomarker for parkinson’s disease market based on protein biomarkers covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Blood-based Biomarker For Parkinson’s Disease Biomarker Type Outlook (Revenue, USD Million, 2021-2033)
- Protein Biomarkers
- Inflammatory Markers
- Metabolic Markers
- Transcriptomic/miRNA
- Others
- Global Blood-based Biomarker For Parkinson’s Disease Technology Outlook (Revenue, USD Million, 2021-2033)
- ELISA/Immunoassay
- Multiplex Platforms
- NGS/qPCR (genetic)
- Mass spectrometry
- Others
- Global Blood-based Biomarker For Parkinson’s Disease End Use Outlook (Revenue, USD Million, 2021-2033)
- Academic/Research Labs
- Pharmaceutical / Biotech
- Hospitals
- Clinical Diagnostic Labs
- Others
Reasons to subscribe to Global blood-based biomarker for parkinson’s disease market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global blood-based biomarker for parkinson’s disease market databook
-
Our clientele includes a mix of blood-based biomarker for parkinson’s disease market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global blood-based biomarker for parkinson’s disease market , including forecasts for subscribers. This global databook contains high-level insights into Global blood-based biomarker for parkinson’s disease market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global blood-based biomarker for parkinson’s disease market size, by regions, 2021-2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
